ANVS

Annovis Bio Inc

NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY

$1.04

-7.14% today

Updated 2026-09-16

Market cap

$47.72M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.65

Dividend yield

—

52W range

$1 – $6

Volume

0.9M

Market cap

$47.72M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.65

Dividend yield

—

52W range

$1 – $6

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →253 stocks currently score above 75

Price targets

Analyst target

$10.50

+909.62%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-21.91M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-25.15M	$-56.20M	$-24.59M	$-28.85M	$-14.82M
EPS	—	—	—	—	$-1.65
Free cash flow	$-17.31M	$-39.97M	$-21.89M	$-25.62M	$-21.91M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANVS	$47.72M	17	4.3	3.0	5.0	5.5	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	2.7	6.0	-88.93%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-69.36%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-73.74%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	6.0	-16.10%	Buy

Smart narrative

Annovis Bio Inc trades at $1.04. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Annovis Bio Inc's stock price?

Annovis Bio Inc (ANVS) trades at $1.04.

Is Annovis Bio Inc overvalued?

Annovis Bio Inc carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Annovis Bio Inc (ANVS)?

The 12-month analyst consensus target is $10.50, about 909.6% above the current $1.04. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNYSE

CurrencyUSD

www.annovisbio.com

Quick metrics

P/S ratio—

ROE-220.60%

Beta1.24

50D MA$1.75

200D MA$2.43

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ANVS vs LLY →ANVS vs JNJ →ANVS vs ABBV →Stock screener →